BioSpace News Archive

Amerigroup Medicare Advantage consumers will be able to use their plan allowance to purchase over-the-counter medications and health-related products at CVS Pharmacy stores

International humanitarian organizations Lutheran World Relief and IMA World Health today announced they are combining operations to dramatically increase their impact on breaking the cycle of poverty and promoting healthier families and communities throughout the world.

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company, today announced that the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) granted Lipocine’s Priority Motion in the interference case, Patent Interference No. 106,045, between Clarus Therapeutics, Inc. (“Clarus”) U.S. Patent No. 8,828,428 (the “Clarus ‘428 Patent”) and Lipocine Inc.

Sound Pharmaceuticals (SPI) is pleased to announce that first-patient-in has been achieved in the STOP Ototoxicity Phase 2 clinical trial.

INVO Bioscience, Inc. (OTCQB: IVOB), developers of the INVOcell intravaginal culture (IVC) system, and Ferring Pharmaceuticals, a specialty biopharmaceutical group committed to helping people around the world build families and live better lives, announced today the closing of the previously announced exclusive U.S. commercialization rights agreement for INVOcell.

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy of [fam-] trastuzumab deruxtecan (DS-8201),

SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases, today announced the appointment of Jane Wright-Mitchell as General Counsel and promotion of Elaine Sun to Chief Strategy Officer and Chief Financial Officer.

FSD fully supports Cannara’s strategic vision and expansion plans and intends to continue working in partnership with Cannara to take advantage of opportunities that benefit both companies

The American Red Cross issued an emergency call today for blood and platelet donors to give now and help mitigate a blood shortage. With holiday scheduling keeping donors busy, the Red Cross collected about 27,000 fewer blood and platelet donations during the weeks of Christmas and New Year’s than needed.

Prior to joining InVivo, Mr. Christopher was the Chief Financial Officer of iCAD, Inc., a Nasdaq-listed company with a focus on therapies and solutions for the early identification and treatment of cancer.